ERYTECH Pharma S.A.
ERYP · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $9,562 | $17,405 | $33,143 | $49,029 |
| - Cash | $38,789 | $0 | $53,339 | $0 |
| + Debt | $13,567 | $0 | $4,007 | $0 |
| Enterprise Value | -$15,660 | $17,405 | -$16,189 | $49,029 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $3,520 | -$1,557 | $16,708 | -$10,835 |
| % Margin | – | – | – | – |
| Net Income | $5,936 | -$5,138 | $10,887 | -$11,911 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.19 | -0.17 | 0.35 | -0.38 |
| % Growth | 211.8% | -148.6% | 192.1% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |